These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21897070)

  • 41. Postremission therapy of acute myeloid leukemia in older adults.
    Schiller GJ
    Leukemia; 1996 Apr; 10 Suppl 1():S18-20. PubMed ID: 8618463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results.
    Ferrara F; Izzo T; Criscuolo C; Riccardi C; Celentano M; Mele G
    Am J Hematol; 2010 Sep; 85(9):687-90. PubMed ID: 20652967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution.
    Vey N; Bouabdallah R; Stoppa A; Faucher C; Lafage M; Chabannon C; Sainty D; Gastaut J; Maraninchi D; Blaise D
    Bone Marrow Transplant; 2004 Jan; 33(2):177-82. PubMed ID: 14647259
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a meta-analysis.
    Bartolozzi B; Bosi A; Orsi C
    Cancer; 2007 Jan; 109(2):343; author reply 344. PubMed ID: 17154182
    [No Abstract]   [Full Text] [Related]  

  • 45. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
    Kiehl MG; Kraut L; Schwerdtfeger R; Hertenstein B; Remberger M; Kroeger N; Stelljes M; Bornhaeuser M; Martin H; Scheid C; Ganser A; Zander AR; Kienast J; Ehninger G; Hoelzer D; Diehl V; Fauser AA; Ringden O
    J Clin Oncol; 2004 Jul; 22(14):2816-25. PubMed ID: 15254049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.
    Schmid C; Schleuning M; Ledderose G; Tischer J; Kolb HJ
    J Clin Oncol; 2005 Aug; 23(24):5675-87. PubMed ID: 16110027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
    Saito T; Kanda Y; Kami M; Kato K; Shoji N; Kanai S; Ohnishi T; Kawano Y; Nakai K; Ogasawara T; Matsubara H; Makimoto A; Tanosaki R; Tobinai K; Wakasugi H; Takaue Y; Mineishi S
    Clin Cancer Res; 2002 Apr; 8(4):1014-20. PubMed ID: 11948108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of hematopoietic stem cell transplantation in acute myelogenous leukemia and myelodysplastic syndrome.
    Tallman MS; Mathews V; DiPersio JF
    Cancer Treat Res; 2009; 144():415-39. PubMed ID: 19779880
    [No Abstract]   [Full Text] [Related]  

  • 49. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.
    Schmid C; Labopin M; Nagler A; Bornhäuser M; Finke J; Fassas A; Volin L; Gürman G; Maertens J; Bordigoni P; Holler E; Ehninger G; Polge E; Gorin NC; Kolb HJ; Rocha V;
    J Clin Oncol; 2007 Nov; 25(31):4938-45. PubMed ID: 17909197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Current treatment of acute myeloid leukemia].
    Ohtake S
    Rinsho Ketsueki; 2012 Oct; 53(10):1560-70. PubMed ID: 23037728
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of acute myeloid leukemia in the elderly].
    Chen Z; Chen J
    Zhonghua Nei Ke Za Zhi; 2001 Apr; 40(4):220-1. PubMed ID: 12945558
    [No Abstract]   [Full Text] [Related]  

  • 52. Pegylated interferon α2a induces complete remission of acute myeloid leukemia in a postessential thrombocythemia myelofibrosis permitting allogenic stem cell transplantation.
    Dagorne A; Douet-Guilbert N; Quintin-Roue I; Guillerm G; Couturier MA; Berthou C; Ianotto JC
    Ann Hematol; 2013 Mar; 92(3):407-9. PubMed ID: 22941306
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of relapsing AML following hematopoietic stem cell transplantation.
    Atlas MP; Lipton JM
    Pediatr Transplant; 2003 Dec; 7(6):419-21. PubMed ID: 14870887
    [No Abstract]   [Full Text] [Related]  

  • 54. Management of acute myeloid leukemia during pregnancy.
    Avivi I; Brenner B
    Future Oncol; 2014 Jun; 10(8):1407-15. PubMed ID: 25052751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High rate of durable remissions post autologous stem cell transplantation for core-binding factor acute myeloid leukaemia in second complete remission.
    Rees MJ; Spencer A; Browett P; Alvaro F; Purtill D; Crawford J; Milliken S; Lai H; Pullon H; Grigg A
    Bone Marrow Transplant; 2020 Nov; 55(11):2207-2210. PubMed ID: 32376971
    [No Abstract]   [Full Text] [Related]  

  • 56. Acute myelogenous leukemia in the elderly.
    Ballester O; Moscinski LC; Morris D; Balducci L
    J Am Geriatr Soc; 1992 Mar; 40(3):277-84. PubMed ID: 1538050
    [No Abstract]   [Full Text] [Related]  

  • 57. Meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data.
    Messori A; Hyeraci G
    Ann Hematol; 2023 Jun; 102(6):1603-1605. PubMed ID: 36877260
    [No Abstract]   [Full Text] [Related]  

  • 58. HSCT prolongs remission of high-risk CTCLs.
    Killock D
    Nat Rev Clin Oncol; 2023 Jul; 20(7):426. PubMed ID: 37147418
    [No Abstract]   [Full Text] [Related]  

  • 59. How do we define complete remission for acute myeloid leukemia in the current era? Results of an international survey.
    Burke MJ; Burns L; Linden MA; Lindgren B; Verneris MR; Weisdorf D; Ustun C
    Am J Hematol; 2013 Sep; 88(9):826-7. PubMed ID: 23737091
    [No Abstract]   [Full Text] [Related]  

  • 60. The optimal donor source for acute myeloid leukemia: do we know the answer?
    Ballen KK
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):749. PubMed ID: 24727331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.